Protective immunity to Bordetella pertussis requires both B cells and CD4(+) T cells for key functions other than specific antibody production
about
Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.The O antigen enables Bordetella parapertussis to avoid Bordetella pertussis-induced immunityRoads to the development of improved pertussis vaccines paved by immunologyUnraveling effector functions of B cells during infection: the hidden world beyond antibody productionWaning and aging of cellular immunity to Bordetella pertussisSuppression of serum antibody responses by pertussis toxin after respiratory tract colonization by Bordetella pertussis and identification of an immunodominant lipoproteinEstimating the duration of pertussis immunity using epidemiological signatures.T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis.Bordetella pertussis proteins dominating the major histocompatibility complex class II-presented epitope repertoire in human monocyte-derived dendritic cellsInfection of newborn piglets with Bordetella pertussis: a new model for pertussisImmunoglobulin A-mediated protection against Bordetella pertussis infection.Molecular signatures of the evolving immune response in mice following a Bordetella pertussis infection.B-cell-deficient mice show an exacerbated inflammatory response in a model of Chlamydophila abortus infection.Pertussis-specific memory B-cell and humoral IgG responses in adolescents after a fifth consecutive dose of acellular pertussis vaccineResurgence of pertussis calls for re-evaluation of pertussis animal models.Maternal immunity provides protection against pertussis in newborn pigletsA live, attenuated Bordetella pertussis vaccine provides long-term protection against virulent challenge in a murine model.Loss of multi-epitope specificity in memory CD4(+) T cell responses to B. pertussis with age.T-cell immune response assessment as a complement to serology and intranasal protection assays in determining the protective immunity induced by acellular pertussis vaccines in mice.B cells enhance early innate immune responses during bacterial sepsis.Bordetella adenylate cyclase toxin differentially modulates toll-like receptor-stimulated activation, migration and T cell stimulatory capacity of dendritic cells.Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model.Cellular immunity in adolescents and adults following acellular pertussis vaccine administration.Bordetella filamentous hemagglutinin and fimbriae: critical adhesins with unrealized vaccine potential.Current advances and challenges in the development of Acinetobacter vaccines.Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine modelSplenic T zone development is B cell dependentSubstantial gaps in knowledge of Bordetella pertussis antibody and T cell epitopes relevant for natural immunity and vaccine efficacyDecreased leukocyte accumulation and delayed Bordetella pertussis clearance in IL-6-/- miceFunctional Immune Cell Differences Associated With Low Vaccine Responses in InfantsImmunodominance in mouse and human CD4+ T-cell responses specific for the Bordetella pertussis virulence factor P.69 pertactin.Immunogenicity of a whole-cell pertussis vaccine with low lipopolysaccharide content in infants.An improved whole cell pertussis vaccine with reduced content of endotoxin.Differential T- and B-cell responses to pertussis in acellular vaccine-primed versus whole-cell vaccine-primed children 2 years after preschool acellular booster vaccination.Age related differences in dynamics of specific memory B cell populations after clinical pertussis infection.Pertussis: a matter of immune modulation.Immunity to the respiratory pathogen Bordetella pertussis.The virulence factors of Bordetella pertussis: talented modulators of host immune response.Mouse and pig models for studies of natural and vaccine-induced immunity to Bordetella pertussis.Improved pertussis vaccines based on adjuvants that induce cell-mediated immunity.
P2860
Q24522458-0B1A8AFA-F5A4-4560-9F93-9C6BB77FE753Q24672570-E3851AD7-B915-432B-AFB8-9057C7B1F5ACQ26782939-417B31F5-5569-4DE7-B62A-09DA54200E08Q27010202-0D0BFCE5-BB5E-4C56-9F4A-93D1DF179ED2Q28080731-C9E3500F-1C53-4416-9600-57B6A9B75A28Q30449521-82DC48BE-9351-4071-A286-DBE254AAE838Q33513972-7BA3EA10-890E-4BB9-94F3-4C869982BD62Q33564283-3EA54958-B405-4547-8E49-23A18FB554E2Q33601872-61B7B54C-EF40-4CBF-847F-F94B1ADEBE81Q33788175-E382B7AF-4905-4891-B1E7-B489D58E01C3Q34008531-AB88376F-1D61-41AC-A35C-3630787D6BA7Q34066406-82A5E5A0-3239-4472-B29B-83E48184709AQ34259955-3B192088-B83D-4CFC-B3A8-8677C51584E2Q34260834-5543E4CF-E41F-423F-A81B-2B61BE0BA52FQ34311615-9B67AFF0-F628-419B-B371-FFC7B4490D38Q34601948-85775514-ACA3-410E-AF73-111AAF3DA2B8Q34738678-DDEB72AB-D5CF-43B6-BDF0-A906F86E122BQ35082532-445D5AFB-3ED2-4F27-8A52-9F95E1A736AFQ35140321-036D60C2-E230-4BAB-9F7A-65B3B9481E5AQ35144572-59224F90-C5A1-4F60-B1E4-DBBC34C6A117Q35217146-3DBC2B6F-1247-4A7D-8509-4CE9DAAB949CQ35220336-27640F4F-FF4A-429C-88D7-643815CF22E9Q35690023-8F39DF2B-D8FA-48FE-9356-A55EC03DFFB9Q36226520-3629133E-2184-410E-B643-C58FB9AEBA52Q36256352-DB97AC29-47B2-400D-BF47-AF3AA0C0100FQ36334703-EF89BE99-CDB0-4B76-A4EB-BB3D5A83CC1FQ36369671-DDA0EC81-B804-44F5-A5F9-0FA8BBBD1D6FQ36688886-42CDAE98-5A36-426F-9EF3-FAD8099798E2Q36746359-043B7DD7-EE0E-4A58-8D97-48D23B8F5542Q36931781-B4931446-0920-43A5-AB93-EA0DFD51F5F8Q37075449-BED35400-C236-4D30-931B-43930715432BQ37156751-8B5DCD81-4AF3-4263-9B0C-6AED11E2EBC4Q37384751-69E39E18-DB4D-40AA-A053-7C489509C723Q37469628-75FD63F6-1531-45BA-8763-8942375B1CAEQ37472929-9D680019-A64A-4CFE-96C2-CFC6CF534C75Q37825920-925A3817-F186-482E-A4F5-E633D146C2AFQ38020419-4C9DA359-6BB8-492A-BDFC-A13DFF96CFCBQ38129761-7F4E8CE5-1D42-44FB-82A3-A53CEE79700DQ38195758-405EDA9E-56F0-432C-B899-A6D43EBA36C7Q38228975-ADB6C8B6-349A-4139-B070-777C4795EA4F
P2860
Protective immunity to Bordetella pertussis requires both B cells and CD4(+) T cells for key functions other than specific antibody production
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Protective immunity to Bordete ...... n specific antibody production
@ast
Protective immunity to Bordete ...... n specific antibody production
@en
type
label
Protective immunity to Bordete ...... n specific antibody production
@ast
Protective immunity to Bordete ...... n specific antibody production
@en
prefLabel
Protective immunity to Bordete ...... n specific antibody production
@ast
Protective immunity to Bordete ...... n specific antibody production
@en
P2093
P2860
P356
P1476
Protective immunity to Bordete ...... n specific antibody production
@en
P2093
P2860
P304
P356
10.1084/JEM.191.11.1841
P407
P577
2000-06-01T00:00:00Z